https://www.selleckchem.com/pr....oducts/4-hydroxytamo
43, 95% CI 0.29-0.57; 59 estimates; χ heterogeneity p0.001; I =92%). SMD was greatest in carotid atherosclerosis (SMD 0.58, 95% CI 0.30-0.86; 17 estimates), followed by coronary (SMD 0.43, 95% CI 0.24-0.62; 33 estimates), lower extremity (SMD 0.26, 95% CI -0.02-0.54; 7 estimates), and renal atherosclerosis (SMD -0.07, 95% CI -2.77-2.64; 2 estimates) (χ heterogeneity p0.001; I ≥80% for all). Subgroup analysis revealed that sCD40L levels were increased in clinical, but not subclinical, atherosclerosis.
Like
Comment
Share
